Shionogi & Co., Ltd. (OTCMKTS:SGIOF) Stock Price Up 4.9% – Should You Buy?

Shionogi & Co., Ltd. (OTCMKTS:SGIOF) shot up 4.9% on Thursday . The company traded as high as $18.89 and last traded at $18.89. 1,560 shares traded hands during mid-day trading, an increase of 44% from the average session volume of 1,080 shares. The stock had previously closed at $18.00.

Shionogi & Co., Ltd. Trading Up 4.9%

The company has a 50 day moving average of $16.64 and a 200-day moving average of $17.05.

About Shionogi & Co., Ltd.

Shionogi & Co, Ltd. is a research-driven pharmaceutical company headquartered in Osaka, Japan, with origins dating back to 1878. The company concentrates on the discovery, development and sale of prescription medicines in key therapeutic areas, including infectious diseases, pain management, cardiovascular and metabolic disorders, central nervous system disorders and oncology. Shionogi’s mission emphasizes addressing unmet medical needs, particularly in the field of antimicrobial resistance, where it has developed both small-molecule antibiotics and novel treatment approaches.

The firm’s product portfolio comprises marketed therapies such as Cresemba (isavuconazole) for invasive fungal infections, and Fetroja (cefiderocol), a siderophore cephalosporin antibiotic for multidrug-resistant Gram-negative infections.